Bexson Biomedical, Inc. – Trademark Portfolio
Entity Type: 03
Bexson Biomedical, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 7 Nice Classification classes. Currently, 0 trademarks are registered and 3 are pending. The owner is based in Santa Barbara, CA.
856 Chelham Way
Santa Barbara, CA 93108
Showing of trademarks Trademarks
Trademark Classifications
Bexson Biomedical, Inc.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Bexson Biomedical, Inc. have?
Bexson Biomedical, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 pending, 1 abandoned.
What trademark classes does Bexson Biomedical, Inc. file in?
Bexson Biomedical, Inc. files trademarks across 7 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What is Bexson Biomedical, Inc.'s trademark registration success rate?
Bexson Biomedical, Inc. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.